


J&J Innovative Medicine Europe, Middle East & Africa (EMEA)
Pharmaceutical Manufacturing • Beerse, Flemish Region, Belgium • 1001-2000 Employees
Company overview
| Headquarters | Beerse, Flemish Region, Belgium |
| Websites | |
| NAICS | 3254 |
| Employees | 1001-2000 |
| Socials |
Key Contacts at J&J Innovative Medicine Europe, Middle East & Africa (EMEA)
Berkin Gökbudak
Senior Director, Commercial Strategy Europe, Middle East And Africa Emea
Maria Fernanda Prado
Managing Director Iberia
Henar Hevia
Senior Director, Emea Therapeutic Area Lead, Oncology
Raghda Elbendary
Commercial Director
Bassem Haidar
Regional Director Lebanon, Syria And Sub Saharan Africa
Tom Denee
Compound Market Access Leader Market Access Director Europe Middle East And Africa Emea
Patrick Sheehy
Senior Director Of Operations, Cork, Ireland
Jonathan Pentel
Country Medical Director, J&J Innovative Medicine France
Reema Bardhan Acharya
Director Regulatory Medical Writing, J&J
Concha Caudevilla Asensio
Senior Director, Emea Therapeutical Area Market Access Leader Cns, Cardiopulm, Epos & Nbd
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) Email Formats
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@janssen.com), used 65.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@janssen.com | 65.6% |
{first initial}.{last name} | j.doe@janssen.com | 15.6% |
{first initial}{last name} | jdoe@janssen.com | 4.7% |
{last name}.{first initial} | doe.j@janssen.com | 3.1% |
About J&J Innovative Medicine Europe, Middle East & Africa (EMEA)
At Johnson & Johnson Innovative Medicine, we are leading where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. Visit our Johnson & Johnson Innovative Medicine EMEA website here: https://innovativemedicine.jnj.com/emea/
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) revenue & valuation
| Annual revenue | $89,900,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $287,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1001-2000
Seniority
Employees
Employees by Department
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) has 489 employees across 17 departments.
Departments
Number of employees
Funding Data
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) has never raised funding before.
Frequently asked questions
4.8
40,000 users



